Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.

Saved in:
Bibliographic Details
Title: Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
Authors: Sattler A; Department for General and Visceral Surgery and., Schrezenmeier E; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Weber UA; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Potekhin A; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.; MVZ Diaverum Neubrandenburg, Neubrandenburg, Germany., Bachmann F; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Straub-Hohenbleicher H; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Budde K; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Storz E; Department for General and Visceral Surgery and., Proß V; Department for General and Visceral Surgery and., Bergmann Y; Department for General and Visceral Surgery and., Thole LM; Department for General and Visceral Surgery and., Tizian C; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany., Hölsken O; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.; Heidelberg Bioscience International Graduate School, Heidelberg University, Heidelberg, Germany., Diefenbach A; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany., Schrezenmeier H; Department of Transfusion Medicine and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen and University Hospital Ulm, Ulm University, Ulm, Germany., Jahrsdörfer B; Department of Transfusion Medicine and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen and University Hospital Ulm, Ulm University, Ulm, Germany., Zemojtel T; Genomics Core Facility., Jechow K; Center for Digital Health, and., Conrad C; Center for Digital Health, and., Lukassen S; Center for Digital Health, and., Stauch D; HLA Laboratory, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany., Lachmann N; HLA Laboratory, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany., Choi M; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Halleck F; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Kotsch K; Department for General and Visceral Surgery and.
Source: The Journal of clinical investigation [J Clin Invest] 2021 Jul 15; Vol. 131 (14).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34101623
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sattler+A%22">Sattler A</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Schrezenmeier+E%22">Schrezenmeier E</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Weber+UA%22">Weber UA</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Potekhin+A%22">Potekhin A</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.; MVZ Diaverum Neubrandenburg, Neubrandenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bachmann+F%22">Bachmann F</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Straub-Hohenbleicher+H%22">Straub-Hohenbleicher H</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Budde+K%22">Budde K</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Storz+E%22">Storz E</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Proß+V%22">Proß V</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Bergmann+Y%22">Bergmann Y</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Thole+LM%22">Thole LM</searchLink>; Department for General and Visceral Surgery and.<br /><searchLink fieldCode="AU" term="%22Tizian+C%22">Tizian C</searchLink>; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hölsken+O%22">Hölsken O</searchLink>; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.; Heidelberg Bioscience International Graduate School, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Diefenbach+A%22">Diefenbach A</searchLink>; Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schrezenmeier+H%22">Schrezenmeier H</searchLink>; Department of Transfusion Medicine and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen and University Hospital Ulm, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Jahrsdörfer+B%22">Jahrsdörfer B</searchLink>; Department of Transfusion Medicine and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service, Baden-Württemberg-Hessen and University Hospital Ulm, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Zemojtel+T%22">Zemojtel T</searchLink>; Genomics Core Facility.<br /><searchLink fieldCode="AU" term="%22Jechow+K%22">Jechow K</searchLink>; Center for Digital Health, and.<br /><searchLink fieldCode="AU" term="%22Conrad+C%22">Conrad C</searchLink>; Center for Digital Health, and.<br /><searchLink fieldCode="AU" term="%22Lukassen+S%22">Lukassen S</searchLink>; Center for Digital Health, and.<br /><searchLink fieldCode="AU" term="%22Stauch+D%22">Stauch D</searchLink>; HLA Laboratory, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lachmann+N%22">Lachmann N</searchLink>; HLA Laboratory, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and BIH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Choi+M%22">Choi M</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Halleck+F%22">Halleck F</searchLink>; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kotsch+K%22">Kotsch K</searchLink>; Department for General and Visceral Surgery and.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2021 Jul 15; Vol. 131 (14).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34101623
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI150175
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sattler A
      – PersonEntity:
          Name:
            NameFull: Schrezenmeier E
      – PersonEntity:
          Name:
            NameFull: Weber UA
      – PersonEntity:
          Name:
            NameFull: Potekhin A
      – PersonEntity:
          Name:
            NameFull: Bachmann F
      – PersonEntity:
          Name:
            NameFull: Straub-Hohenbleicher H
      – PersonEntity:
          Name:
            NameFull: Budde K
      – PersonEntity:
          Name:
            NameFull: Storz E
      – PersonEntity:
          Name:
            NameFull: Proß V
      – PersonEntity:
          Name:
            NameFull: Bergmann Y
      – PersonEntity:
          Name:
            NameFull: Thole LM
      – PersonEntity:
          Name:
            NameFull: Tizian C
      – PersonEntity:
          Name:
            NameFull: Hölsken O
      – PersonEntity:
          Name:
            NameFull: Diefenbach A
      – PersonEntity:
          Name:
            NameFull: Schrezenmeier H
      – PersonEntity:
          Name:
            NameFull: Jahrsdörfer B
      – PersonEntity:
          Name:
            NameFull: Zemojtel T
      – PersonEntity:
          Name:
            NameFull: Jechow K
      – PersonEntity:
          Name:
            NameFull: Conrad C
      – PersonEntity:
          Name:
            NameFull: Lukassen S
      – PersonEntity:
          Name:
            NameFull: Stauch D
      – PersonEntity:
          Name:
            NameFull: Lachmann N
      – PersonEntity:
          Name:
            NameFull: Choi M
      – PersonEntity:
          Name:
            NameFull: Halleck F
      – PersonEntity:
          Name:
            NameFull: Kotsch K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: 2021 Jul 15
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 131
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1